MedPath

A Phase I Study of Weekly Nab-Paclitaxel/Carboplatin in Chemotherapy-Naive Patients with Advanced Non-Small-Cell Lung Cancer

Phase 1
Conditions
previously untreated advanced non-small cell lung cancer
Registration Number
JPRN-UMIN000012788
Lead Sponsor
Department of Respiratory Medicine in Hyogo Prefectural Amagasaki Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)History of radiotherapy for a primary lesion 2)Superior vena cava syndrome 3)Hisstory of severe drug allergy 4)With massive or uncontrolled pleural effusion 5)With massive or uncontrolled pericardial effusionor ascites 6)With active infection 7)interstitial pneumoia/active lung fibrosis on chest x-ray 8)With symptomatic brain metastasis 9)active concomitant malignancy 10)Uncontrolled psychiatric disease 11)Peripheral sensory or motor neuropathy severe than Grade 2(by CTCAE ver4.0) 12)Others judged by attending physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath